Cancer immunotherapy has transformed the treatment landscape by helping the immune system recognize and attack tumors. At the ...

"Pancreatic cancer is what is known as a 'cold tumor,' meaning it has few infiltrated immune cells and therefore immunotherapy usually does not work," argues Rovira.

Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

A specially engineered antibody capable of delivering RNA therapies to hard-to-reach, treatment-resistant tumors ...

Integrated biomarker analyses confirm viral replication, interferon signaling, and a surge in tumor-infiltrating lymphocytes ...

Oncolytics Biotech reveals promising survival data for pelareorep, an innovative immunotherapy, showing significant benefits ...

Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a leading clinical-stage company ...

CAN-2409 is an investigational, off-the-shelf, replication-defective adenovirus engineered to deliver the herpes simplex virus thymidine kinase (HSV-tk) gene to tumor cells. When administered with a ...

Penetrium™ Achieves Historic BreakthroughOvercoming Cold Tumor Failure and the Challenge of Metastatic Cancer in Immunotherapy and Antibody TherapyPresented at AACR 2025, Chicago ...